General Information
Drug ID
DR00692
Drug Name
Cefdinir
Synonyms
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; BMY 28488; CFDN; Cefdinir (JP15/USAN/INN); Cefdinir [USAN:INN]; Cefdinirum; Cefdinirum [INN-Latin]; Cefdinyl; Cefdirnir; Cefzon; Cefzon (TN); FK 482; FK-482; FR-80482; KS-1038; Omnicef; Omnicef (TN); Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir; PD 134393; PD-134393
Drug Type
Small molecular drug
Indication Bacterial infections [ICD11: 1A00-1H0Z] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C14H13N5O5S2
Canonical SMILES
C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O
InChI
InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
InChIKey
RTXOFQZKPXMALH-GHXIOONMSA-N
CAS Number
CAS 91832-40-5
Pharmaceutical Properties Molecular Weight 395.4 Topological Polar Surface Area 212
Heavy Atom Count 26 Rotatable Bond Count 5
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 10
XLogP
0
PubChem CID
6915944
PubChem SID
10310 , 103241607 , 104253245 , 114784936 , 12013492 , 124637292 , 124757367 , 124766167 , 125164171 , 125311797 , 126592899 , 126670303 , 131330280 , 134222573 , 134337732 , 135013391 , 135693788 , 136368001 , 137003422 , 143493270 , 144075787 , 144089123 , 144115805 , 144240157 , 14805465 , 14927923 , 152090681 , 152242898 , 152344175 , 160963880 , 17193404 , 25819898 , 26612828 , 26680572 , 43527984 , 46386833 , 46505573 , 47943747 , 48169352 , 49679095 , 50050916 , 50123150 , 52583972 , 56422579 , 57371624 , 7847980 , 92124803 , 92308050 , 92729947 , 93166985
ChEBI ID
CHEBI:3485
TTD Drug ID
D0WS1X
DT(s) Transporting This Drug OAT3 Transporter Info Organic anion transporter 3 Substrate [2]
PEPT1 Transporter Info Peptide transporter 1 Substrate [3]
References
1 Cefdinir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005 Oct 1;70(7):1104-13.
3 Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov Today. 2004 Aug 15;9(16):712-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.